MedPath

Lemonex Inc.

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Study of Single Ascending Dose of LEM-S401 in Healthy Participants

Phase 1
Completed
Conditions
Cicatrix
Scar Prevention
Interventions
Drug: Placebo
First Posted Date
2021-01-13
Last Posted Date
2023-02-16
Lead Sponsor
Lemonex Inc.
Target Recruit Count
19
Registration Number
NCT04707131
Locations
🇰🇷

Chungbuk National University Hospital, Cheongju, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.